Inactive Instrument

News SDS Biotech K.K.

Equities

4952

JP3163200003

Summary

Unlock all the news: Be the first to know and act before the market!

Idemitsu Kosan Co.,Ltd. completed the acquisition of remaining 30.3% stake in SDS Biotech K.K. from group of sellers.	21-07-27	CI
Idemitsu Kosan Co.,Ltd. entered into Share Exchange Agreement to acquire remaining 30.3% stake in SDS Biotech K.K. from group of sellers for ¥3.1 billion.	21-05-10	CI
Ex-dividend day for final dividend	21-03-29	FA
SDS Biotech K.K. Reports Earnings Results for the Second Quarter of 2021	20-11-27	CI
Ex-dividend day for interim dividend	20-09-28	FA
Ex-dividend day for final dividend	20-03-29	FA
SDS Biotech K.K. Announces Consolidated Financial Results for the Nine Months Ended December 31, 2019; Provides Consolidated Financial Guidance for the Year Ending March 31, 2020	20-02-05	CI
Ex-dividend day for interim dividend	19-09-26	FA
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Guidance for the Full Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter of Fiscal Year 2020 and Full Year Ending March 31, 2020	19-07-30	CI
Ex-dividend day for final dividend	19-03-26	FA
Ex-dividend day for interim dividend	18-09-25	FA
Sds Biotech K.K. Announces Consolidated Earnings Results for the Year Ended March 31, 2018	18-05-14	CI
Ex-dividend day for final dividend	18-03-27	FA
R.Narasimhan, R.Padmanaban, R.Gopal completed the acquisition of an additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K..	18-03-26	CI
SDS Ramcides Cropscience Private Limited announced that it expects to receive INR 1.32 billion in funding from SDS Biotech K.K.	18-03-12	CI
R.Narasimhan, R.Padmanaban, R.Gopal entered into an agreement to acquire additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K. for INR 0.21 million.	18-03-12	CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the Third Quarter Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Year Ending March 31, 2018	18-02-05	CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018	17-11-01	CI
Ex-dividend day for interim dividend	17-09-26	FA
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2018	17-08-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SDS Biotech K.K.

Equities

4952

JP3163200003

Summary

Filters